Tune Therapeutics: Funding, Investors & Team (Oct 2026)
Tune Therapeutics aims to create innovative cell and gene therapies that utilize epigenetic programming to treat severe illnesses.
Tune Therapeutics has raised $215M across 2 funding rounds on record, the most recent a Series B of $175M announced in Jan 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Tune Therapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Tune Therapeutics Funding Rounds
Tune Therapeutics raised $40.0M in a Series A announced in Dec 2021.
3.1 years later, a Series B of $175M was announced in Jan 2025.
Tune Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Tune Therapeutics Funding Compared to Other Biotechnology Startups
Tune Therapeutics' latest round of $175M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tune Therapeutics in Biotechnology and Seattle
Companies Similar to Tune Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Tune Therapeutics Funding FAQs
What does Tune Therapeutics do?
Tune Therapeutics aims to create innovative cell and gene therapies that utilize epigenetic programming to treat severe illnesses.
How much funding has Tune Therapeutics raised?
Tune Therapeutics has raised $215M across 2 rounds on record. The most recent is a Series B of $175M announced in Jan 2025.
When did Tune Therapeutics last raise funding?
Tune Therapeutics' most recent funding round on record is a Series B of $175M, announced in Jan 2025.
Who founded Tune Therapeutics?
FundedIQ lists Fyodor Urnov (Founder) at Tune Therapeutics.
Who is the CEO of Tune Therapeutics?
Matt Kane is listed as CEO at Tune Therapeutics.
Where is Tune Therapeutics headquartered?
Tune Therapeutics is based in Seattle, Washington, United States.
How many employees does Tune Therapeutics have?
Tune Therapeutics is in the 51-100 employee band.
How does Tune Therapeutics' funding compare to other Biotechnology startups?
Tune Therapeutics' latest round of $175M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Tune Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tune Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.